Epstein Robert S
CIK 0001252004
Director
Filings
18
Latest May 22, 2026
Issuers covered
3
Showing
18 of 18
Page 1
Track record
2 of 3 open-market trades scored (67% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -7.9% | -7.9% | +0.4% | -16.1% |
| 90 days | 2 | 0% | -13.2% | -13.2% | -9.6% | -16.8% |
| 180 days | 2 | 100% | +17.7% | +17.7% | +19.6% | +15.9% |
| 365 days | 1 | 0% | -10.6% | -10.6% | -10.6% | -10.6% |
Issuers
Companies where Epstein Robert S has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VCYT | Veracyte, Inc. | 8 | May 22, 2026 |
| FATE | Fate Therapeutics Inc | 5 | May 6, 2026 |
| ILMN | Illumina, Inc. | 5 | May 23, 2025 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|